Abraham, J. E., O’Connor, L. O., Grybowicz, L., Alba, K. P., Dayimu, A., Demiris, N., . . . Group, P. T. Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial. Nature Portfolio.
Chicago Style (17th ed.) CitationAbraham, Jean E., et al. Neoadjuvant PARP Inhibitor Scheduling in BRCA1 and BRCA2 Related Breast Cancer: PARTNER, a Randomized Phase II/III Trial. Nature Portfolio.
MLA (9th ed.) CitationAbraham, Jean E., et al. Neoadjuvant PARP Inhibitor Scheduling in BRCA1 and BRCA2 Related Breast Cancer: PARTNER, a Randomized Phase II/III Trial. Nature Portfolio.
Warning: These citations may not always be 100% accurate.